Back to top

Piper Sandler Keeps Their Hold Rating on 10x Genomics (TXG)

Piper Sandler analyst David Westenberg maintained a Hold rating on 10x Genomics today and set a price target of $42.00. Westenberg covers the Healt...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

10x Genomics (TXG)